Lebanon

Lebanon

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.31 (1.03 - 1.64) 2015 Modelled WHO
1.2 (1.10 - 1.30) 2016 Modelled Razavi-Shearer et al, 2018
1.21 (1.10 - 1.34) 2013 Modelled Schweitzer et al, 2015
2.82 (2.43 - 3.24) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3.28 (2.86 - 3.74) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3.37 (2.91 - 3.85) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3.36 (2.91 - 3.83) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3.35 (2.86 - 3.84) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3.37 (2.87 - 3.85) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3.43 (2.91 - 3.91) 2013 Modelled IHME, GBD 2019 (accessed 2022)
3.52 (2.97 - 4.02) 2012 Modelled IHME, GBD 2019 (accessed 2022)
3.6 (2.99 - 4.14) 2011 Modelled IHME, GBD 2019 (accessed 2022)
3.65 (3 - 4.20) 2010 Modelled IHME, GBD 2019 (accessed 2022)
3.7 (3.08 - 4.26) 2009 Modelled IHME, GBD 2019 (accessed 2022)
3.8 (3.20 - 4.36) 2008 Modelled IHME, GBD 2019 (accessed 2022)
3.92 (3.30 - 4.50) 2007 Modelled IHME, GBD 2019 (accessed 2022)
4.02 (3.40 - 4.66) 2006 Modelled IHME, GBD 2019 (accessed 2022)
4.07 (3.46 - 4.74) 2005 Modelled IHME, GBD 2019 (accessed 2022)
4.1 (3.51 - 4.78) 2004 Modelled IHME, GBD 2019 (accessed 2022)
4.16 (3.56 - 4.85) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4.24 (3.62 - 4.97) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4.31 (3.66 - 5.10) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4.34 (3.67 - 5.19) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4.38 (3.71 - 5.21) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4.46 (3.76 - 5.29) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4.56 (3.79 - 5.38) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4.65 (3.82 - 5.49) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4.7 (3.83 - 5.54) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4.72 (3.89 - 5.52) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4.75 (3.96 - 5.53) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4.77 (4.03 - 5.54) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.8 (4.08 - 5.58) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4.83 (4.11 - 5.59) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.09 (2.68 - 3.55) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.21 (0.14 - 0.30) 2015 Modelled WHO
0.58 (0.43 - 0.76) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.75 (0.56 - 0.99) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.62 - 1.09) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.64 - 1.15) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.64 - 1.11) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.63 - 1.10) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.65 - 1.12) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.67 - 1.17) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.71 - 1.24) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.74 - 1.31) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.05 (0.77 - 1.37) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.11 (0.82 - 1.46) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.19 (0.88 - 1.56) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.27 (0.94 - 1.66) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.34 (0.99 - 1.75) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.36 (0.99 - 1.79) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.35 (0.99 - 1.77) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.32 (0.97 - 1.72) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.29 (0.95 - 1.68) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.26 (0.93 - 1.66) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.25 (0.92 - 1.66) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.48 (1.09 - 1.95) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.04 (1.49 - 2.67) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.72 (1.97 - 3.53) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.29 (2.39 - 4.27) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.56 (2.56 - 4.65) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.6 (2.64 - 4.66) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.63 (2.68 - 4.66) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.66 (2.72 - 4.67) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3.67 (2.74 - 4.70) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.66 (2.73 - 4.67) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.06 - 0.09) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
70,000 (66,000 - 77,000) 2016 Modelled Razavi-Shearer et al, 2018
145,964 (126,047 - 167,629) 2019 Modelled IHME, GBD 2019 (accessed 2020)
151,363 (131,551 - 173,735) 2019 Modelled IHME, GBD 2019 (accessed 2022)
159,006 (138,589 - 180,518) 2018 Modelled IHME, GBD 2019 (accessed 2022)
161,915 (139,417 - 184,610) 2017 Modelled IHME, GBD 2019 (accessed 2022)
160,080 (138,447 - 182,862) 2016 Modelled IHME, GBD 2019 (accessed 2022)
158,206 (134,911 - 181,225) 2015 Modelled IHME, GBD 2019 (accessed 2022)
158,442 (134,983 - 181,104) 2014 Modelled IHME, GBD 2019 (accessed 2022)
158,947 (134,833 - 181,573) 2013 Modelled IHME, GBD 2019 (accessed 2022)
154,680 (129,859 - 176,773) 2012 Modelled IHME, GBD 2019 (accessed 2022)
147,384 (122,452 - 169,010) 2011 Modelled IHME, GBD 2019 (accessed 2022)
142,989 (116,982 - 164,281) 2010 Modelled IHME, GBD 2019 (accessed 2022)
143,129 (118,902 - 164,175) 2009 Modelled IHME, GBD 2019 (accessed 2022)
145,874 (122,983 - 167,206) 2008 Modelled IHME, GBD 2019 (accessed 2022)
149,039 (125,574 - 171,346) 2007 Modelled IHME, GBD 2019 (accessed 2022)
151,119 (127,409 - 175,280) 2006 Modelled IHME, GBD 2019 (accessed 2022)
150,842 (127,335 - 176,447) 2005 Modelled IHME, GBD 2019 (accessed 2022)
149,867 (127,751 - 175,424) 2004 Modelled IHME, GBD 2019 (accessed 2022)
150,278 (128,503 - 175,916) 2003 Modelled IHME, GBD 2019 (accessed 2022)
151,272 (129,507 - 177,523) 2002 Modelled IHME, GBD 2019 (accessed 2022)
152,174 (129,784 - 180,394) 2001 Modelled IHME, GBD 2019 (accessed 2022)
152,148 (128,709 - 181,766) 2000 Modelled IHME, GBD 2019 (accessed 2022)
152,046 (128,681 - 180,935) 1999 Modelled IHME, GBD 2019 (accessed 2022)
153,085 (129,267 - 181,346) 1998 Modelled IHME, GBD 2019 (accessed 2022)
154,572 (128,464 - 181,925) 1997 Modelled IHME, GBD 2019 (accessed 2022)
155,644 (127,907 - 183,333) 1996 Modelled IHME, GBD 2019 (accessed 2022)
155,314 (126,453 - 182,720) 1995 Modelled IHME, GBD 2019 (accessed 2022)
153,951 (126,768 - 179,618) 1994 Modelled IHME, GBD 2019 (accessed 2022)
152,656 (126,816 - 177,547) 1993 Modelled IHME, GBD 2019 (accessed 2022)
151,464 (127,512 - 175,773) 1992 Modelled IHME, GBD 2019 (accessed 2022)
150,234 (127,511 - 174,254) 1991 Modelled IHME, GBD 2019 (accessed 2022)
148,828 (126,648 - 172,226) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
6.02 (4.24 - 9.08) 2019 Modelled IHME, GBD 2019 (accessed 2020)
7.92 (5.70 - 10.30) 1990 Modelled IHME, GBD 2019 (accessed 2022)
7.91 (5.69 - 10.30) 1991 Modelled IHME, GBD 2019 (accessed 2022)
7.94 (5.73 - 10.32) 1992 Modelled IHME, GBD 2019 (accessed 2022)
7.94 (5.81 - 10.24) 1993 Modelled IHME, GBD 2019 (accessed 2022)
7.85 (5.78 - 10.11) 1994 Modelled IHME, GBD 2019 (accessed 2022)
7.77 (5.74 - 9.88) 1995 Modelled IHME, GBD 2019 (accessed 2022)
7.45 (5.57 - 9.49) 1997 Modelled IHME, GBD 2019 (accessed 2022)
7.65 (5.66 - 9.76) 1996 Modelled IHME, GBD 2019 (accessed 2022)
7.26 (5.43 - 9.34) 1998 Modelled IHME, GBD 2019 (accessed 2022)
7.12 (5.31 - 9.40) 1999 Modelled IHME, GBD 2019 (accessed 2022)
7.09 (5.31 - 9.40) 2000 Modelled IHME, GBD 2019 (accessed 2022)
7.17 (5.37 - 9.62) 2001 Modelled IHME, GBD 2019 (accessed 2022)
7.25 (5.40 - 9.90) 2002 Modelled IHME, GBD 2019 (accessed 2022)
7.33 (5.42 - 10.16) 2003 Modelled IHME, GBD 2019 (accessed 2022)
7.5 (5.51 - 10.44) 2005 Modelled IHME, GBD 2019 (accessed 2022)
7.42 (5.47 - 10.49) 2004 Modelled IHME, GBD 2019 (accessed 2022)
7.49 (5.47 - 10.52) 2006 Modelled IHME, GBD 2019 (accessed 2022)
7.32 (5.30 - 10.38) 2007 Modelled IHME, GBD 2019 (accessed 2022)
7.04 (5.07 - 10.19) 2008 Modelled IHME, GBD 2019 (accessed 2022)
6.64 (4.69 - 10.04) 2010 Modelled IHME, GBD 2019 (accessed 2022)
6.78 (4.85 - 10.10) 2009 Modelled IHME, GBD 2019 (accessed 2022)
6.49 (4.62 - 9.86) 2011 Modelled IHME, GBD 2019 (accessed 2022)
6.17 (4.36 - 9.32) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5.97 (4.23 - 8.99) 2013 Modelled IHME, GBD 2019 (accessed 2022)
5.97 (4.19 - 8.99) 2014 Modelled IHME, GBD 2019 (accessed 2022)
6.02 (4.24 - 9.07) 2015 Modelled IHME, GBD 2019 (accessed 2022)
6.16 (4.37 - 9.29) 2017 Modelled IHME, GBD 2019 (accessed 2022)
6.09 (4.32 - 9.18) 2016 Modelled IHME, GBD 2019 (accessed 2022)
6.13 (4.30 - 9.28) 2018 Modelled IHME, GBD 2019 (accessed 2022)
6.02 (4.24 - 9.08) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
426 2016 Modelled WHO
260 (187 - 337) 1990 Modelled IHME, GBD 2019 (accessed 2022)
263 (189 - 342) 1991 Modelled IHME, GBD 2019 (accessed 2022)
268 (193 - 348) 1992 Modelled IHME, GBD 2019 (accessed 2022)
271 (198 - 350) 1993 Modelled IHME, GBD 2019 (accessed 2022)
272 (200 - 350) 1994 Modelled IHME, GBD 2019 (accessed 2022)
272 (201 - 346) 1995 Modelled IHME, GBD 2019 (accessed 2022)
271 (201 - 346) 1996 Modelled IHME, GBD 2019 (accessed 2022)
263 (197 - 339) 1998 Modelled IHME, GBD 2019 (accessed 2022)
267 (200 - 341) 1997 Modelled IHME, GBD 2019 (accessed 2022)
261 (195 - 345) 1999 Modelled IHME, GBD 2019 (accessed 2022)
263 (197 - 348) 2000 Modelled IHME, GBD 2019 (accessed 2022)
273 (204 - 373) 2002 Modelled IHME, GBD 2019 (accessed 2022)
268 (200 - 359) 2001 Modelled IHME, GBD 2019 (accessed 2022)
286 (211 - 405) 2004 Modelled IHME, GBD 2019 (accessed 2022)
280 (207 - 387) 2003 Modelled IHME, GBD 2019 (accessed 2022)
294 (215 - 408) 2005 Modelled IHME, GBD 2019 (accessed 2022)
297 (217 - 417) 2006 Modelled IHME, GBD 2019 (accessed 2022)
294 (213 - 417) 2007 Modelled IHME, GBD 2019 (accessed 2022)
285 (205 - 413) 2008 Modelled IHME, GBD 2019 (accessed 2022)
277 (198 - 413) 2009 Modelled IHME, GBD 2019 (accessed 2022)
275 (195 - 416) 2010 Modelled IHME, GBD 2019 (accessed 2022)
282 (200 - 428) 2011 Modelled IHME, GBD 2019 (accessed 2022)
288 (203 - 435) 2012 Modelled IHME, GBD 2019 (accessed 2022)
293 (208 - 442) 2013 Modelled IHME, GBD 2019 (accessed 2022)
298 (209 - 448) 2014 Modelled IHME, GBD 2019 (accessed 2022)
301 (212 - 454) 2015 Modelled IHME, GBD 2019 (accessed 2022)
307 (218 - 463) 2016 Modelled IHME, GBD 2019 (accessed 2022)
313 (222 - 472) 2017 Modelled IHME, GBD 2019 (accessed 2022)
314 (221 - 476) 2018 Modelled IHME, GBD 2019 (accessed 2022)
312 (219 - 470) 2019 Modelled IHME, GBD 2019 (accessed 2022)
312 (219 - 470) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
19 (15 - 23) 1990 Modelled IHME, GBD 2019 (accessed 2022)
21 (17 - 26) 1991 Modelled IHME, GBD 2019 (accessed 2022)
22 (18 - 27) 1993 Modelled IHME, GBD 2019 (accessed 2022)
22 (17 - 27) 1992 Modelled IHME, GBD 2019 (accessed 2022)
22 (18 - 27) 1994 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 28) 1995 Modelled IHME, GBD 2019 (accessed 2022)
24 (19 - 29) 1997 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 29) 1998 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 28) 1996 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 29) 1999 Modelled IHME, GBD 2019 (accessed 2022)
24 (18 - 29) 2000 Modelled IHME, GBD 2019 (accessed 2022)
24 (18 - 30) 2001 Modelled IHME, GBD 2019 (accessed 2022)
24 (18 - 30) 2002 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 29) 2004 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 29) 2003 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 29) 2005 Modelled IHME, GBD 2019 (accessed 2022)
22 (18 - 28) 2006 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 29) 2007 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 29) 2009 Modelled IHME, GBD 2019 (accessed 2022)
22 (17 - 29) 2008 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 29) 2011 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 29) 2010 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 29) 2012 Modelled IHME, GBD 2019 (accessed 2022)
21 (15 - 29) 2013 Modelled IHME, GBD 2019 (accessed 2022)
21 (15 - 30) 2014 Modelled IHME, GBD 2019 (accessed 2022)
21 (15 - 30) 2015 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 31) 2016 Modelled IHME, GBD 2019 (accessed 2022)
22 (16 - 31) 2017 Modelled IHME, GBD 2019 (accessed 2022)
22 (16 - 32) 2019 Modelled IHME, GBD 2019 (accessed 2022)
22 (15 - 31) 2018 Modelled IHME, GBD 2019 (accessed 2022)
49 (40 - 58) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
80 2019 Survey/reported WHO/UNICEF
80 2018 Survey/reported WHO/UNICEF
80 2017 Survey/reported WHO/UNICEF
80 2016 Survey/reported WHO/UNICEF
80 2015 Survey/reported WHO/UNICEF
80 2014 Survey/reported WHO/UNICEF
80 2013 Survey/reported WHO/UNICEF
83 2012 Survey/reported WHO/UNICEF
86 2011 Survey/reported WHO/UNICEF
88 2010 Survey/reported WHO/UNICEF
91 2009 Survey/reported WHO/UNICEF
94 2008 Survey/reported WHO/UNICEF
94 2007 Survey/reported WHO/UNICEF
94 2006 Survey/reported WHO/UNICEF
94 2005 Survey/reported WHO/UNICEF
94 2004 Survey/reported WHO/UNICEF
94 2003 Survey/reported WHO/UNICEF
94 2002 Survey/reported WHO/UNICEF
90 2001 Survey/reported WHO/UNICEF
90 2000 Survey/reported WHO/UNICEF
77 2020 Survey/reported WHO/UNICEF
80 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
80 2019 Survey/reported WHO/UNICEF
71 2020 Survey/reported WHO/UNICEF
67 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2000
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.2 (0.10 - 0.40) 2015 Modelled Blach et al, 2017
1.09 (0.89 - 1.35) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.66 - 0.98) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.67 (0.55 - 0.81) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.66 (0.54 - 0.79) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.54 - 0.78) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.53 - 0.77) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.53 - 0.77) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.53 - 0.78) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.66 (0.55 - 0.80) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.67 (0.56 - 0.81) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.57 - 0.83) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.60 - 0.87) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.63 - 0.91) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.65 - 0.95) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.65 - 0.97) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.65 - 0.96) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.64 - 0.95) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.63 - 0.94) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.63 - 0.92) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.62 - 0.92) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.62 - 0.91) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.62 - 0.91) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.63 - 0.92) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.64 - 0.94) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.66 - 0.96) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.68 - 0.99) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.73 - 1.05) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.77 - 1.13) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.83 - 1.22) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.08 (0.88 - 1.32) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.84 - 1.26) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.12 (0.05 - 0.28) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.21 2019 Modelled Jin et al. 2017
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
0 (0 - 97.50) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
23.4 (15.30 - 33.30) 2013 Survey/reported Merabi Z et al, 2016
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
0 2019 Modelled Jin et al. 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
8,000 (3,000 - 18,000) 2015 Modelled Blach et al, 2017
33,359 (27,120 - 40,920) 1990 Modelled IHME, GBD 2019 (accessed 2022)
31,513 (25,885 - 38,064) 1991 Modelled IHME, GBD 2019 (accessed 2022)
29,776 (24,617 - 35,763) 1992 Modelled IHME, GBD 2019 (accessed 2022)
28,277 (23,423 - 33,920) 1993 Modelled IHME, GBD 2019 (accessed 2022)
27,153 (22,257 - 32,434) 1994 Modelled IHME, GBD 2019 (accessed 2022)
26,531 (21,655 - 31,901) 1995 Modelled IHME, GBD 2019 (accessed 2022)
26,240 (21,472 - 31,576) 1996 Modelled IHME, GBD 2019 (accessed 2022)
26,024 (21,370 - 31,352) 1997 Modelled IHME, GBD 2019 (accessed 2022)
25,942 (21,371 - 31,194) 1998 Modelled IHME, GBD 2019 (accessed 2022)
26,048 (21,433 - 31,509) 1999 Modelled IHME, GBD 2019 (accessed 2022)
26,387 (21,712 - 32,024) 2000 Modelled IHME, GBD 2019 (accessed 2022)
26,928 (22,116 - 32,720) 2001 Modelled IHME, GBD 2019 (accessed 2022)
27,569 (22,685 - 33,580) 2002 Modelled IHME, GBD 2019 (accessed 2022)
28,266 (23,173 - 34,389) 2003 Modelled IHME, GBD 2019 (accessed 2022)
28,960 (23,649 - 35,241) 2004 Modelled IHME, GBD 2019 (accessed 2022)
29,615 (24,110 - 36,005) 2005 Modelled IHME, GBD 2019 (accessed 2022)
29,682 (24,454 - 35,912) 2006 Modelled IHME, GBD 2019 (accessed 2022)
28,900 (23,877 - 34,773) 2007 Modelled IHME, GBD 2019 (accessed 2022)
27,732 (22,843 - 33,277) 2008 Modelled IHME, GBD 2019 (accessed 2022)
26,703 (22,048 - 32,079) 2009 Modelled IHME, GBD 2019 (accessed 2022)
26,454 (21,781 - 31,918) 2010 Modelled IHME, GBD 2019 (accessed 2022)
27,223 (22,485 - 32,821) 2011 Modelled IHME, GBD 2019 (accessed 2022)
28,504 (23,623 - 34,344) 2012 Modelled IHME, GBD 2019 (accessed 2022)
29,567 (24,566 - 35,586) 2013 Modelled IHME, GBD 2019 (accessed 2022)
30,094 (24,964 - 36,257) 2014 Modelled IHME, GBD 2019 (accessed 2022)
30,552 (25,327 - 36,861) 2015 Modelled IHME, GBD 2019 (accessed 2022)
31,229 (25,826 - 37,574) 2016 Modelled IHME, GBD 2019 (accessed 2022)
32,073 (26,356 - 38,878) 2017 Modelled IHME, GBD 2019 (accessed 2022)
38,985 (31,931 - 47,370) 2018 Modelled IHME, GBD 2019 (accessed 2022)
53,057 (43,337 - 65,348) 2019 Modelled IHME, GBD 2019 (accessed 2020)
53,530 (43,743 - 65,905) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
2,300 (870 - 5,300) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
5.48 (3.30 - 8.35) 2019 Modelled IHME, GBD 2019 (accessed 2020)
4.66 (3.32 - 6.07) 1990 Modelled IHME, GBD 2019 (accessed 2022)
4.66 (3.32 - 6.08) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4.68 (3.34 - 6.10) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.69 (3.35 - 6.15) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4.64 (3.32 - 6.08) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4.62 (3.31 - 6.10) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4.62 (3.31 - 6.12) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4.74 (3.38 - 6.33) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4.65 (3.34 - 6.14) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4.78 (3.41 - 6.44) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4.81 (3.40 - 6.53) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4.85 (3.38 - 6.65) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4.87 (3.37 - 6.71) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4.92 (3.35 - 6.87) 2004 Modelled IHME, GBD 2019 (accessed 2022)
4.9 (3.36 - 6.77) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4.96 (3.37 - 6.91) 2005 Modelled IHME, GBD 2019 (accessed 2022)
5.05 (3.38 - 7.07) 2006 Modelled IHME, GBD 2019 (accessed 2022)
5.24 (3.48 - 7.32) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5.46 (3.53 - 7.66) 2008 Modelled IHME, GBD 2019 (accessed 2022)
5.75 (3.63 - 8.20) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5.67 (3.58 - 7.96) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5.64 (3.54 - 8.17) 2011 Modelled IHME, GBD 2019 (accessed 2022)
5.38 (3.32 - 7.85) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5.21 (3.13 - 7.79) 2013 Modelled IHME, GBD 2019 (accessed 2022)
5.22 (3.14 - 7.78) 2014 Modelled IHME, GBD 2019 (accessed 2022)
5.26 (3.16 - 7.90) 2015 Modelled IHME, GBD 2019 (accessed 2022)
5.31 (3.18 - 8) 2017 Modelled IHME, GBD 2019 (accessed 2022)
5.28 (3.15 - 7.94) 2016 Modelled IHME, GBD 2019 (accessed 2022)
5.38 (3.26 - 8.22) 2018 Modelled IHME, GBD 2019 (accessed 2022)
5.48 (3.30 - 8.35) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
301 2016 Modelled WHO
284 (171 - 432) 2019 Modelled IHME, GBD 2019 (accessed 2022)
284 (171 - 432) 2019 Modelled IHME, GBD 2019 (accessed 2020)
276 (167 - 421) 2018 Modelled IHME, GBD 2019 (accessed 2022)
270 (162 - 406) 2017 Modelled IHME, GBD 2019 (accessed 2022)
267 (159 - 400) 2016 Modelled IHME, GBD 2019 (accessed 2022)
263 (158 - 396) 2015 Modelled IHME, GBD 2019 (accessed 2022)
260 (156 - 388) 2014 Modelled IHME, GBD 2019 (accessed 2022)
256 (154 - 382) 2013 Modelled IHME, GBD 2019 (accessed 2022)
251 (155 - 366) 2012 Modelled IHME, GBD 2019 (accessed 2022)
245 (154 - 354) 2011 Modelled IHME, GBD 2019 (accessed 2022)
238 (150 - 340) 2010 Modelled IHME, GBD 2019 (accessed 2022)
232 (146 - 325) 2009 Modelled IHME, GBD 2019 (accessed 2022)
221 (143 - 310) 2008 Modelled IHME, GBD 2019 (accessed 2022)
210 (140 - 294) 2007 Modelled IHME, GBD 2019 (accessed 2022)
200 (134 - 281) 2006 Modelled IHME, GBD 2019 (accessed 2022)
194 (132 - 271) 2005 Modelled IHME, GBD 2019 (accessed 2022)
190 (129 - 265) 2004 Modelled IHME, GBD 2019 (accessed 2022)
187 (128 - 258) 2003 Modelled IHME, GBD 2019 (accessed 2022)
184 (127 - 253) 2002 Modelled IHME, GBD 2019 (accessed 2022)
181 (126 - 248) 2001 Modelled IHME, GBD 2019 (accessed 2022)
178 (126 - 242) 2000 Modelled IHME, GBD 2019 (accessed 2022)
175 (125 - 236) 1999 Modelled IHME, GBD 2019 (accessed 2022)
172 (123 - 230) 1998 Modelled IHME, GBD 2019 (accessed 2022)
167 (120 - 220) 1997 Modelled IHME, GBD 2019 (accessed 2022)
164 (117 - 217) 1996 Modelled IHME, GBD 2019 (accessed 2022)
162 (116 - 214) 1995 Modelled IHME, GBD 2019 (accessed 2022)
161 (115 - 210) 1994 Modelled IHME, GBD 2019 (accessed 2022)
160 (114 - 210) 1993 Modelled IHME, GBD 2019 (accessed 2022)
158 (113 - 205) 1992 Modelled IHME, GBD 2019 (accessed 2022)
155 (110 - 202) 1991 Modelled IHME, GBD 2019 (accessed 2022)
153 (109 - 199) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
8 (5 - 11) 1990 Modelled IHME, GBD 2019 (accessed 2022)
9 (5 - 12) 1991 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 1992 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 1993 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 1995 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 1994 Modelled IHME, GBD 2019 (accessed 2022)
10 (6 - 14) 1996 Modelled IHME, GBD 2019 (accessed 2022)
10 (6 - 14) 1997 Modelled IHME, GBD 2019 (accessed 2022)
10 (6 - 14) 1998 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 1999 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 15) 2000 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 15) 2001 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 15) 2004 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 15) 2002 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 15) 2003 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 15) 2005 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2006 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 15) 2007 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 15) 2008 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 15) 2009 Modelled IHME, GBD 2019 (accessed 2022)
10 (6 - 15) 2010 Modelled IHME, GBD 2019 (accessed 2022)
10 (6 - 15) 2011 Modelled IHME, GBD 2019 (accessed 2022)
10 (6 - 15) 2012 Modelled IHME, GBD 2019 (accessed 2022)
10 (6 - 15) 2013 Modelled IHME, GBD 2019 (accessed 2022)
10 (6 - 15) 2014 Modelled IHME, GBD 2019 (accessed 2022)
10 (6 - 15) 2016 Modelled IHME, GBD 2019 (accessed 2022)
10 (6 - 16) 2015 Modelled IHME, GBD 2019 (accessed 2022)
10 (6 - 16) 2017 Modelled IHME, GBD 2019 (accessed 2022)
10 (6 - 16) 2018 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 17) 2019 Modelled IHME, GBD 2019 (accessed 2022)
23 (16 - 32) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2000
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
2.82 (%)
2019
(2.43 - 3.24(%))
IHME, GBD 2019 (accessed 2020)
HCV (RNA/cAg+)
1.09 (%)
2019
(0.89 - 1.35(%))
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
312
2019
(219 - 470)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
284
2019
(171 - 432)
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.07 (%)
2020, latest modelled
(0.06 - 0.09(%))
WHO

Prevalence PWID

HCV
23.40 (%)
2013, survey/surveillance
(15.30 - 33.30(%))
Merabi Z et al, 2016

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
80 (%)
2021
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources